Skip to main content
. Author manuscript; available in PMC: 2018 Mar 20.
Published in final edited form as: Br J Nutr. 2016 Sep 8;116(7):1165–1174. doi: 10.1017/S0007114516002968

Table 3.

Odds ratios(95% CI) for metabolic syndrome and its components per SD of iron markers in the whole sample

Z score log-sTfR Z score log-ferritin Z score log-sTfR/ferritin ratio
Non-adjusted Adjusted* Non-adjusted Adjusted* Non-adjusted Adjusted*
High glucose 1.11 (0.95-1.29) 1.10 (0.92-1.30) 1.48 (1.27-1.74) 1.31 (1.06-1.61) 0.73 (0.62-0.85) 0.83 (0.68-1.02)
Low HDL-C 1.16 (0.98-1.36) 0.98 (0.76-1.25) 0.46 (0.38-0.56) 1.40 (1.06-1.84) 2.07 (1.69-2.53) 0.75 (0.57-0.98)
High TG 1.02 (0.88-1.19) 1.05 (0.89-1.24) 1.71 (1.44-2.03) 1.67 (1.34-2.09) 0.63 (0.53-0.75) 0.68 (0.55-0.83)
High BP 1.09 (0.93-1.28) 1.05 (0.88-1.27) 1.52 (1.30-1.78) 1.14 (0.90-1.44) 0.71 (0.61-0.84) 0.92 (0.74-1.14)
High WC 1.16 (0.97-1.39) 1.02 (0.84-1.24) 1.09 (0.91-1.29) 1.30 (1.01-1.68) 0.96 (0.81-1.15) 0.82 (0.65-1.04)
MetS 1.09 (0.94-1.27) 0.97 (0.82-1.15) 1.41 (1.21-1.65) 1.92 (1.52-2.43) 0.76 (0.65-0.88) 0.60 (0.49-0.75)
*

Age, fibrinogen levels, smoking status (yes/no/ex-smoker), alcohol consumption (no/yes), and sex/menopausal status (premenopausal women/postmenopausal women/men).

Includes additionally individuals who reported current use of oral hypoglycemic medications or insulin regardless of fasting glucose values.

Includes additionally individuals who reported current use of antihypertensive medications regardless of blood pressure values. TG, triglycerides. BP, blood pressure.. WC, waist circumference. HDL-C, HDL cholesterol. MetS, metabolic syndrome. Significant associations are show in bold (P<0.05).